Tom H. Ottenhoff
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mycobacterial growth control is heterogeneous but maintained during treatment in patients with tuberculosis disease.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: January 09, 2026
Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in humans.
Journal: Molecular immunology
Published: March 27, 2022
Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
Journal: Seminars in immunology
Published: July 02, 2018
NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.
Journal: JCI insight
Published: June 19, 2018
Mycobacterial growth inhibition is associated with trained innate immunity.
Journal: The Journal of clinical investigation
Published: September 14, 2017
Long-lasting tuberculous pleurisy.
Journal: The European respiratory journal
Published: February 20, 2017
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis.
Journal: The European respiratory journal
Published: May 20, 2016
Cold acclimation affects immune composition in skeletal muscle of healthy lean subjects.
Journal: Physiological reports
Published: July 08, 2015
Last Updated: 09/26/2026